RE: SP Angel Vadim Alexandre Broker Note12 Apr 2021 12:36
Here you go.... this is what SP Angel had to say:
"Whilst the lack of a contract extension is expected to impact FY21 revenues, this is mitigated by international sales and private sector testing operations which contributed to half of Q121 trading. The Group is continuing to rollout PROmate™ in hospitals, private sector settings and international markets as well as launching additional products over the year, such as lateral flow tests. The contract dispute isa disappointing outcome for both parties, however, Novacyt has taken legal advice and believes it has strong grounds to assert its contractual rights. Given the uncertainty regarding the DHSC contract and limited visibility over future sales we have withdrawn our forecasts and have put our target price under review"